These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7242187)

  • 21. Repeated nonanesthetic malignant hyperthermia reactions in a child.
    Cummings T; Der T; Karsli C
    Paediatr Anaesth; 2016 Dec; 26(12):1202-1203. PubMed ID: 27562486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant hyperthermia: responses of skeletal muscles to general anesthetics.
    Gallant EM; Ahern CP
    Mayo Clin Proc; 1983 Nov; 58(11):758-63. PubMed ID: 6355673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Malignant hyperthermia].
    Grote B
    Anaesthesist; 1980 Feb; 29(2):53-4. PubMed ID: 7377524
    [No Abstract]   [Full Text] [Related]  

  • 24. Anaesthesia in malignant hyperthermia-susceptible patients without dantrolene prophylaxis: a report of 30 cases.
    Hackl W; Mauritz W; Winkler M; Sporn P; Steinbereithner K
    Acta Anaesthesiol Scand; 1990 Oct; 34(7):534-7. PubMed ID: 2244439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant hyperthermia.
    Faust DK
    Alaska Med; 1985; 27(1):1-2. PubMed ID: 2988361
    [No Abstract]   [Full Text] [Related]  

  • 26. Propofol and malignant hyperthermia susceptibility.
    Pollock AN; McKenzie AJ; Hodges M; Snoeck MM
    Anaesth Intensive Care; 1997 Oct; 25(5):583-5. PubMed ID: 9352778
    [No Abstract]   [Full Text] [Related]  

  • 27. Dantrolene in porcine malignant hyperthermia.
    Gronert GA; Milde JH; Theye RA
    Anesthesiology; 1976 Jun; 44(6):488-95. PubMed ID: 1275316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant hyperpyrexia.
    Denborough MA
    Med J Aust; 1977 Dec; 2(23):757-8. PubMed ID: 611371
    [No Abstract]   [Full Text] [Related]  

  • 29. Dantrium: the approved drug to control malignant hyperthermia.
    Gever LN
    Nursing; 1980 Jul; 10(7):62. PubMed ID: 6900937
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experimental study of dantrolene sodium in anesthetic malignant hyperthermia in the pietrain-strain pig].
    Adnet P; Krivosic-Horber R; Guevart E; Theunynck D; Vincent A
    Cah Anesthesiol; 1986 Oct; 34(6):463-7. PubMed ID: 3801956
    [No Abstract]   [Full Text] [Related]  

  • 31. Malignant hyperthermia: a review of published cases.
    Strazis KP; Fox AW
    Anesth Analg; 1993 Aug; 77(2):297-304. PubMed ID: 8346828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dantrolene sodium is able to reduce the resting ionic [Ca2+]i in muscle from humans with malignant hyperthermia.
    López JR; Medina P; Alamo L
    Muscle Nerve; 1987 Jan; 10(1):77-9. PubMed ID: 3561441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Verapamil is not a therapeutic adjunct to dantrolene in porcine malignant hyperthermia.
    Gallant EM; Foldes FF; Rempel WE; Gronert GA
    Anesth Analg; 1985 Jun; 64(6):601-6. PubMed ID: 4003778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant hyperthermia testing in probands without adverse anesthetic reaction.
    Timmins MA; Rosenberg H; Larach MG; Sterling C; Kraeva N; Riazi S
    Anesthesiology; 2015 Sep; 123(3):548-56. PubMed ID: 26068069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Successful treatment of malignant hyperthermia with dantrolene-sodium and uneventful re-anaesthesia after oral dantrolene-prophylaxis (author's transl)].
    Schulte-Sasse U; Tarnow J; Eberlein HJ
    Anaesthesist; 1982 May; 31(5):241-4. PubMed ID: 6896607
    [No Abstract]   [Full Text] [Related]  

  • 36. Malignant hyperthermia.
    Denborough M
    Lancet; 1998 Oct; 352(9134):1131-6. PubMed ID: 9798607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant hyperthermia: clinical course and metabolic changes in two patients.
    Rutberg H; Håkanson E
    Acta Anaesthesiol Scand; 1986 Apr; 30(3):211-4. PubMed ID: 3739577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant hyperpyrexia.
    Fisk GC
    Anaesth Intensive Care; 1977 Aug; 5(3):195-6. PubMed ID: 900458
    [No Abstract]   [Full Text] [Related]  

  • 39. Current understanding of malignant hyperthermia: genesis, prevention, and treatment.
    Katz DN
    CRNA; 1992 May; 3(2):54-63. PubMed ID: 1483145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of prophylactic or therapeutic efficacy of 5-HT2A receptor antagonists in halothane-induced porcine malignant hyperthermia.
    Löscher W; Gerdes C; Richter A
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):365-74. PubMed ID: 7845474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.